Home
Supported by an independent educational grant from Servier. Join us for an interactive a nd engaging symposium that takes a deep dive into the latest clinical evidence for novel therapies targeting IDH -mutant gliomas and how this can be translated into clinical practice, including expert perspectives on providing individualized, comprehensive care that maximizes long-term outcomes for your patients. Chief, Division of Neuro-Oncology Boston, Massachusetts, United States Miami, Florida, United